| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $12K | +5.5% |
| Cost of Revenue | $14K | +2.8% |
| Gross Profit | -$2K | +11.1% |
| R&D Expense | $96K | +445.9% |
| SG&A Expense | $3.2M | -61.2% |
| Operating Income | -$3.3M | +59.9% |
| Net Income | -$4.5M | +47.7% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $270K | +30.9% |
| Short-term Investments | $15K | — |
| Current Assets | $349K | -86.8% |
| Total Assets | $1.1M | -66.0% |
| Current Liabilities | $1.1M | -37.5% |
| Total Liabilities | $2.5M | +46.6% |
| Stockholders' Equity | -$1.4M | -202.6% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$582K | +16.4% |
| Capital Expenditures | $252K | +4222.5% |
| Investing Cash Flow | $286K | +146.5% |
| Financing Cash Flow | $350K | -76.7% |
| Free Cash Flow | -$834K | -18.8% |